Home Amines 4936-47-4
4936-47-4,MFCD00057257
Catalog No.:AA00I8RQ

4936-47-4 | 2-Oxazolidinone,5-[(methylthio)methyl]-3-[[(5-nitro-2-furanyl)methylene]amino]-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%(HPLC)
in stock  
$54.00   $38.00
- +
5g
98%(HPLC)
in stock  
$150.00   $105.00
- +
25g
98%(HPLC)
in stock  
$531.00   $372.00
- +
100g
98%(HPLC)
in stock  
$1,383.00   $968.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00I8RQ
Chemical Name:
2-Oxazolidinone,5-[(methylthio)methyl]-3-[[(5-nitro-2-furanyl)methylene]amino]-
CAS Number:
4936-47-4
Molecular Formula:
C10H11N3O5S
Molecular Weight:
285.2764
MDL Number:
MFCD00057257
SMILES:
[O-][N+](=O)c1ccc(o1)/C=N/N1CC(OC1=O)CSC
Properties
Computed Properties
 
Complexity:
386  
Covalently-Bonded Unit Count:
1  
Defined Bond Stereocenter Count:
1  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
7  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
1  
XLogP3:
0.7  

Literature

Title: Bacterial vaginosis, Atopobium vaginae and nifuratel.

Journal: Current clinical pharmacology 20120201

Title: [Rifaksimin in complex treatment of Helicobacter pylori infection in children (a pilot study)].

Journal: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101

Title: Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

Journal: Journal of medicinal chemistry 20081113

Title: Nifuratel-containing initial anti-Helicobacter pylori triple therapy in children.

Journal: Helicobacter 20070401

Title: An improved HPLC method for determination of nifuratel in human plasma and its application to pharmacokinetics studies.

Journal: European journal of drug metabolism and pharmacokinetics 20070101

Title: Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone.

Journal: Alimentary pharmacology & therapeutics 20051101

Title: ['Mixed' and 'miscellaneous' vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel].

Journal: Ceska gynekologie 20050501

Title: Determination of nifuratel in human plasma by HPLC and study on its pharmacokinetics.

Journal: Journal of chromatographic science 20050401

Title: [The Melkersson-Rosenthal syndrome as a problem of complex treatment].

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960) 20040101

Title: Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections.

Journal: Arzneimittel-Forschung 20030101

Title: Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice.

Journal: Journal of the National Cancer Institute 19751101

Title: Polatti F. Bacterial vaginosis, Atopobium vaginae and nifuratel. Curr Clin Pharmacol. 2012 Feb 1;7(1):36-40.

Title: Nijevitch AA, et al. Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy withnifuratel to furazolidone. Aliment Pharmacol Ther. 2005 Nov 1;22(9):881-7.

Title: Nijevitch AA, et al. Nifuratel-containing initial anti-Helicobacter pylori triple therapy in children. Helicobacter. 2007 Apr;12(2):132-5.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 4936-47-4
Tags:4936-47-4 Molecular Formula|4936-47-4 MDL|4936-47-4 SMILES|4936-47-4 2-Oxazolidinone,5-[(methylthio)methyl]-3-[[(5-nitro-2-furanyl)methylene]amino]-